Literature DB >> 1422846

Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil.

N Nakata1, H Kato, K Kogure.   

Abstract

To clarify the role of serotonin in cerebral ischemia, we examined the effects of selective serotonin reuptake inhibitors, citalopram and clomipramine, on ischemic neuronal damage in the gerbil. Pretreatment with citalopram (40 mg/kg i.p.) and clomipramine (20 mg/kg i.p.) protected against neuronal destruction of hippocampal CA1 pyramidal cells following 5 min of forebrain ischemia. Furthermore, microdialysis assays showed that a striking increase in extracellular excitatory amino acid levels during ischemia was significantly inhibited by pretreatment with citalopram and clomipramine. However, citalopram (40 mg/kg i.p.) did not alter the extracellular amino acid concentrations in normal gerbils. Thus, serotonin reuptake inhibitors have a protective effect against ischemic neuronal damage. Furthermore, the present result suggests that the protective effect is mediated through prevention of the accumulation of extracellular excitatory amino acids during and after ischemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422846     DOI: 10.1016/0006-8993(92)91080-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Evaluation of monoaminergic neurotransmitters in the acute focal ischemic human brain model by intracerebral in vivo microdialysis.

Authors:  R Kanthan; A Shuaib; R Griebel; H el-Alazounni; H Miyashita; J Kalra
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

2.  Alterations in serotonin receptors and transporter immunoreactivities in the hippocampus in the rat unilateral hypoxic-induced epilepsy model.

Authors:  Sung-Jin An; Duk-Soo Kim
Journal:  Cell Mol Neurobiol       Date:  2011-06-17       Impact factor: 5.046

3.  Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Richard K Sterling; R Todd Stravitz; Arun J Sanyal; Velimir Luketic; Michael Fuchs; Ho Chong S Gilles; James B Wade
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

Review 4.  Comparison of the effects of serotonin in the hippocampus and the entorhinal cortex.

Authors:  D Schmitz; T Gloveli; R M Empson; U Heinemann
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

5.  Increases of Catalase and Glutathione Peroxidase Expressions by Lacosamide Pretreatment Contributes to Neuroprotection Against Experimentally Induced Transient Cerebral Ischemia.

Authors:  Hyun Young Choi; Joon Ha Park; Bai Hui Chen; Bich Na Shin; Yun Lyul Lee; In Hye Kim; Jeong-Hwi Cho; Tae-Kyeong Lee; Jae-Chul Lee; Moo-Ho Won; Ji Hyeon Ahn; Hyun-Jin Tae; Bing Chun Yan; In Koo Hwang; Jun Hwi Cho; Young-Myeong Kim; Sung Koo Kim
Journal:  Neurochem Res       Date:  2016-05-21       Impact factor: 3.996

6.  Changes in Energy Levels by Dexamethasone in Ischemic Hearts and Brains in Male Mice.

Authors:  Toshihiro Yorozuya; Chikara Namba; Naoto Adachi; Kazuo Nakanishi; Kentaro Dote; Takumi Nagaro
Journal:  J Neurosurg Anesthesiol       Date:  2015-10       Impact factor: 3.956

7.  Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology.

Authors:  Irina G Stavrovskaya; Malini V Narayanan; Wenhua Zhang; Boris F Krasnikov; Jill Heemskerk; S Stanley Young; John P Blass; Abraham M Brown; M Flint Beal; Robert M Friedlander; Bruce S Kristal
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.